Skip to content
Stocks:
4,977
ETFs:
2,264
Exchanges:
11
Market Cap:
$66.37T
24h Vol:
$10.04B
Dominance: AAPL:
5.06 %

Meta’s 2023 R&D Intensity of 29.7% Is the Highest Among the Magnificent 7

user image

By Edith Muthoni

Updated Jan 31, 2024

Meta Platforms has emerged as a frontrunner, boasting the highest Research and Development (R&D) intensity among the renowned Magnificent 7. With an impressive 2023 R&D intensity of 29.7%, Meta Platforms has solidified its commitment to innovation and cutting-edge advancements. This is according to Stocklytics.com`s analysis. 

In a comparative analysis of tech giants, Meta’s R&D intensity outshines competitors. This includes Alphabet (14.67%), Microsoft (12.84%), Amazon (15.23%), Apple (7.80%), NVIDIA (18.17%), and Tesla (4.10%). Meta’s commitment to innovation is evident, setting a new standard in the industry.

Stocklytics Financial analyst Edith Reads commented on the data,

Meta Platforms’ commitment to Research and Development exemplifies their strategic pursuit of innovation. By dedicating substantial resources to R&D, the company embraces the cutting edge of technology and reinforces its position as a leader in shaping the digital landscape. Through their ongoing exploration of transformative technologies, Meta Platforms is actively shaping the future of connectivity, signalling a dedication to pushing boundaries and delivering groundbreaking solutions.

Stocklytics Financial Analyst Edith Reads

Tech Industry’s R&D Surge

In the last five quarters, major players in the tech industry have significantly ramped up their investments in Research and Development (R&D). This is in response to the disruptive influence of AI and the swift pace of innovation.

As these technologies continue to permeate our daily lives, there has been a corresponding surge in R&D expenditure among leading corporations.

During the latest quarter, Amazon (AMZN.US) allocated over $21 billion to R&D, surpassing the investment levels of Meta Platforms (META.US) and Apple (AAPL.US), which were less than half of Amazon’s commitment. 

Amazon’s sustained high R&D spending focused on enhancing its technological infrastructure, spanning software to autonomous vehicles.

Meta’s Strategic Shift to Generative AI

Meta Platforms, the parent company of Facebook, devoted nearly a third of its quarterly revenues to R&D. This marked the highest proportion among the seven companies analyzed. Most of Meta’s R&D investments were channelled through its research arm, Reality Labs, which initially focused on constructing a metaverse. However, in response to a lukewarm reception, the company shifted its focus to generative AI.

In 2023, chipmaker NVIDIA (NVDA.US) witnessed a remarkable surge in market capitalization. Over the past five quarters, NVIDIA’s Return on Research Capital (RORC) experienced rapid growth, reaching a peak of 4.54X in the third quarter, placing the company at the forefront among tech giants.

Microsoft (MSFT.US), on the other hand, demonstrated steady growth and secured the second position in the third quarter with a 4.04X RORC. This further signals substantial commercial profits generated by the AI wave.

The significance of Meta’s R&D endeavours extends beyond financial metrics. It symbolizes a proactive approach to shaping the future of connectivity. Meta Platforms is not just participating in the technology race; it is actively driving it, setting new standards for innovation, and solidifying its position as a pioneer in the digital realm.

3D Email Image

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

...
Successfully subscribed
Stocklytics Logo

© 2024 Stocklytics. All rights reserved.

Disclaimer: The information provided by Stocklytics is for general informational purposes only and should not be considered as investment advice. We make no representation regarding the completeness or accuracy of the data, and it should not be relied upon for investment decisions. Use of this tool is at your own risk, and we are not liable for any loss or damage arising from its use.